Abstract
Vaccination against rabies was discovered by L. Pasteur a hundred years ago. If the original “Pasteur's treatment” is no longer used, various types of neural tissue vaccines, prepared from the brain of experimentally infected animals, are still produced and applied in many countries. These vaccines are poorly protective and often responsible for untoward reactions.
Cell cultures have introduced the rabies vaccines into a new and modern era.
From inoculated cell cultures rabies virus may be obtained in a pure form and in large amounts. Concentrated and purified virus may be used for the preparation of highly immunogenic and well tolerated vaccines, applicable either to pre-exposure immunization or to post-exposure rabies treatment.
With the newly introduced biotechnologies, such as the large bioreactors and the micro-carriers, these cell culture rabies vaccines may be produced at an industrial scale and at a reasonable cost.
Preview
Unable to display preview. Download preview PDF.
References
Steele, J. H.: History of rabies, in: The Natural History of Rabies (Baer, G. M., ed.) p. 1, New York-San Francisco-London, Acad. Press 1975
World Survey of Rabies XXI, WHO/Rabics/84.195 (ed.) World Health Organization, Geneva, 1984
Galtier, P. V.: C. R. Acad. Sci. (Paris) 93, 284 (1881)
Pasteur, L.: ibid. 92, 1259 (1881)
Pasteur, L.: ibid. 98, 457 (1884)
Pasteur, L.: ibid. 98, 1229 (1884)
Pasteur, L.: ibid. 101, 765 (1885)
Högyes, A.: Orv. Hetil. 31, 121 (1887)
Puscariu, E., Vesesco, E.: Ann. Inst. Pasteur 9, 210 (1895)
Babès, V.: Traité de la Rage, Paris, Baillères et Fils (1912)
Fermi, C.: Z. Hyg. Infektionskr. 58, 233 (1908)
Semple, D.: Sci. Mem. Med. Sanit. Dep. India, no 44 (1911)
Hempt, A.: Ann. Inst. Pasteur 39, 362 (1925)
Lépine, P., Atanasiu, P., Gamet, A., Vialat, C.: Phenolized, freeze dried sheep brain vaccine. Method used at the Pasteur Institute, Paris, in: Laboratory Techniques in Rabies (Kaplan, M. M. & Koprowski, H. eds.) p. 204, Geneva, W.H.O., 19733
Fuenzalida, E., Palacios, R.: Biol. Inst. Bacteriol., Chile 8, 3 (1955)
Svet-Moldavskij, G. J. A., Andjaparidze, O. G., Unanov, S. S., Karakajumcan, M. K., Svet-Moldavskaja, I. A., Mucnik, L. S., Hieninson, M. A., Ravkina, L. I., Mtvarelidze, A. A., Volkova, O. F., Kriegshaber, M. R., Kalinkina, A. G., Salita, T. V., Klimovickaja, V. I., Bondaletova, I. N., Rojhel, V. M., Kiseleva, I. S., Levcenko, E. N., Marennikova, S. S., Leonidova, S. L.: An Allergen-Free Antirabies Vaccine. Bull. World Health Organization 32, 47 (1965)
Gispen, R., Saathof, B.: Arch. gesamte Virusforsch. 15, 377 (1965)
Powell, H. M., Culbertson, C. G.: Pub. Health Rep. 65, 400 (1950)
Glück, R., Keller, H., Mischler, R., Wegmann, A., Germanier, R.: New aspects concerning the immunogenicity of rabies vaccines produced in animal brains (Duck-embryo), in: Rabies in the Tropics (Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. eds.) p. 181, Berlin-Heidelberg-New York-Tokyo, Springer-Verlag 1985
Wegmann, A., Glück, R., Keller, H., Matthieu, J. M.: Schweiz. Medizin. Wochensch. 49, 115 (1985)
Stoel, G.: C. R. Soc. Biol. 104, 851 (1930)
Wiktor, T. J., Clarck, H. F.: Growth of rabies virus in cell cultures, in: The Natural History of Rabies (Baer, G. M. ed.) p. 115, New York-San Francisco-London, Acad. Press 1975
Plotz, J., Reagan, R.: Science 95, 102 (1942)
Levaditi, C., Schoen, R., Rénié, L.: Ann. Inst. Pasteur 58, 353 (1937)
Pearson, H. E., Atanasiu, P., Lépine, P.: ibid. 94, 1 (1958)
Atanasiu, P., Lépine, P.: ibid. 96, 72 (1959)
Vieuchange, J., Vialat, C., Gruest, J., Bequignon, R.: ibid. 90, 361 (1956)
Vieuchange, J., Bequignon, R., Gruest, J., Vialat, C.: Bull. Acad. Natl. Méd. Paris, 5/6, 77 (1958)
Kissling, R. E.: Proc. Soc. Exp. Biol. Med. 98, 223 (1958)
Fenje, P.: Canad. J. Microbiol. 6, 479 (1960)
Kissling, R. E., Reese, D. R.: J. Immunol. 91, 362 (1963)
Abelseth, M. K.: Canad. Vet. J. 5, 84 (1964)
Abelseth, M. K.: ibid. 5, 279 (1964)
Kondo, A.: Virology 27, 199 (1965)
MacPherson, I., Stoker, M.: ibid. 16, 147 (1962)
Wiktor, T. J., Sokol, F., Kuwert, E., Koprowski, H.: Proc. Soc. Exp. Biol. Med. 131, 799 (1969)
Diamond, L.: Int. J. Cancer 2, 143 (1967)
Precausta, P.: Symp. Series immunobiol. Standard 21, 162 (1974)
Hayflick, L., Moorhead, P. S.: Exp. Cell Res. 25, 585 (1961)
Wiktor, T. J., Fernandes, M. V., Koprowski, H.: J. Immunol. 93, 353 (1964)
Jacob, J. P., Jones, C. M., Baille, J. P.: Nature 277, 168 (1970)
Rhim, J. S., Schell, K., Creasy, B., Case, W.: Proc. Soc. Exp. Biol. Med. 132, 670 (1969)
Levenbook, I. S., Petricciani, J. C., Elisberg, B. L.: J. Biol. Standard 12, 391 (1984)
Levenbook, I. S., Petricciani, J. C., Qi, Y., Elisberg, B. L., Rogers, J. L., Jackson, L. B., Wierenga, D. E., Webster, B. A.: ibid. 13, 135 (1985)
Stoker, M., O'Neill, C., Berryman, S., Waxman, V.: Int. J. Cancer 3, 683 (1968)
Van Wezel, A. L.: Nature 216, 64 (1967)
Van Wezel, A. L.: Progr. immunobiol. Standard 5, 187 (1972)
Van Wezel, A. L.: Microcarrier cultures of animal cells, in: Tissue Culture methods and application (Kruse, P. F., Patterson, M. K. eds.) p. 372, New York-London, Acad. Press 1973
Van Wezel, A. L.: Develop. biol. Standard 37, 143 (1976)
Meigner, B.: ibid. 42, 141 (1979)
Van Wezel, A. L., van der Velden-de Groot, C. A. M., van Herwaarden, J. A. M.: ibid. 46, 151 (1980)
Montagnon, B. J., Fanget, B., Nicolas, A. J.: ibid. 47, 55 (1981)
Fenje, P., Pinteric, L.: Amer. J. Pub. Hlth 56, 2106 (1966)
Fenje, P.: Symp. Series immunobiol. Standard 21, 148 (1974)
Selimov, M. A., Aksenova, T. A.: ibid. 1, 377 (1966)
Selimov, M. A., Aksenova, T., Gribencha, L., Kljueva, E., Guliev, M., Mirozoeva, S., Kocofane, V., Anina-Radcenko, N., Markkarjan, A., Stepanova, I., Kuznecova, A., Presnecova, N., Andreeva, S., Fursova, A., Soluha, E.: ibid. 21, 179 (1974)
Selimov, M. A., Aksenova, T., Klyueva, E., Gribencha, L., Lebedeva, I.: ibid. 40, 57 (1978)
Selimov, M. A., Klyueva, E. V., Aksenova, T. A., Lebedeva, I. R., Gribencha, L. F.: ibid. 40, 141 (1978)
Lin Fang-Tao, Zeng Fan-zhen, Lu Long-mu, Lu Xiao-Zen, Zen Rongfang, Yu Yongrin, Chang Nai-min: J. Infect. Dis. 147, 467 (1983)
Lin Fang-Tao, Lu Xiao-zeng, Cheng Shu-beng, Wang Guao-fu, Zeng Fan-zhen, Lu Long-mu, Cheng Nai-min, Fang Ji-zui: Further study on the stability and efficacy of the primary hamster kidney cell rabies vaccine, in: Improvements in rabies post-exposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 37, Zagreb Institute of Public Health 1985
Atanasiu, P., Tsiang, H., Gamet, A.: Ann. Microbiol. (Inst. Pasteur) 125B, 419 (1974)
Atanasiu, P., Tsiang, H., Lavergne, M., Chermann, J. C.: ibid. 128B, 297 (1977)
Atanasiu, P., Tsiang, H., Reculard, P., Aguilon, F., Lavergne, M., Adamowicz, Ph.: Develop. biol. Standard. 40, 35 (1978)
Guesry, P., Sureau, P., Lery, L., Cerisier, Y., Gamet, A., Atanasiu, P.: Comparative clinical trial of three different rabies vaccines used in pre-exposure vaccination, in: Cell Culture Rabies Vaccines and their protective Effect in Man (Kuwert, E. K., Wiktor, T. J., Koprowski, H. eds.) p. 314, Geneva, International Green Cross 1981
Sureau, P., Rollin, P. E., Loucq, C.: Ann. Virol. (Inst. Pasteur) 135E, 277 (1984)
Sureau, P., Rollin, P. E., Fritzell, B., Loucq, C., Marie, F. N., Courrier, A., Simonnet, Ph., Arbogast, J., Fremont, J., Gaudiot, C., Malo, J. P.: Reactogenicity and immunogenicity of primary fetal bovine kidney cells (FBKC) rabies vaccine: post-exposure treatment in: Improvements in rabies post-exposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 47, Zagreb Institute of Public Health 1985
Van Wezel, A. L., Van Steenis, G.: Develop. biol. Standard. 40, 69 (1978)
Van Steenis, G., Van Wezel, A. L., Van der Marel, P. J., Hannik, Ch. A.: Dog kidney cell rabies vaccine: some aspects of its control and efficacy in man, in: Cell culture rabies vaccines and their protective effect in man (Kuwert, E., Wiktor, T. J., Koprowski, H. eds.) p. 78, Geneva, International Green Cross 1981
Van Steenis, G., Van Wezel, A. L., Hannik, Ch. A., Van der Marel, P., Osterhaus, A. D. M. E., de Grott, I. G. M., Koning, C., Lelyveld, J. L. M., Ruitenberg, E. J.: Immunogenicity of dog kidney cell rabies vaccine (DKCV), in: Rabies in the Tropics (Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. eds.) p. 172, Berlin-Heidelberg-New York-Tokyo, Springer-Verlag 1985
Kondo, A., Takashima, Y., Suzuki, M.: Symp. Series immunobiol. Standard 21, 182 (1974)
Barth, R., Gruschkau, H., Bijok, U., Hilfenhaus, J., Hinz, J., Milcke, L., Moser, H., Jaeger, O., Ronneberger, H., Weinmann, E.: J. Biol. Stand. 12, 29 (1984)
Barth, R., Gruschkau, H., Jaeger, O., Milcke, L., Weinmann, E.: Behring Inst. Mitt. 76, 142 (1984)
Bijok, U., Barth, R., Gruschkau, H., Vodopija, I., Smerdel, S., Kukla, H.: Clinical trials in healthy volunteers with the new purified chick embryo cell rabies vaccine in man, in: Rabies in the Tropics (Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. eds.) p. 125, Berlin-Heidelberg-New York-Tokyo, Springer-Verlag 1985
Bijok, U.: Purified chick embryo cell (PCEC) rabies vaccine: a review of clinical development 1982–1984, in: Improvements in rabies post-exposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 103, Zagreb Institute of Public Health 1985
Vodopija, I., Smerdel, S., Bijok, U.: P.C.E.C. rabies vaccine and HRIG in post-exposure protection against rabies, in: Rabies in the Tropics (Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. eds.) p. 133, Berlin-Heidelberg-New York-Tokyo, Springer-Verlag 1985
Wasi, C., Chaiprasithikul, P., Puthavathana, P., Chavanich, L., Thongcharoen, P.: Immunogenicity and reactogenicity of the new tissue culture rabies vaccine for human use (Purified chick embryo cell culture), in Improvements in rabies post-exposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 85, Zagreb Institute of Public Health 1985
Wasi, C., Chaiprasithikul, P., Chavanich, L., Puthavathna, P., Thongcharoen, P., Trishanananda, M.: Lancet 40, 8471 (1986)
Sehgal, S.: Report on the trials of the P.C.E.C. (Purified chick embryo cell) rabies vaccine in India, in: Improvements in rabies post-exposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 71, Zagreb Institute of Public Health 1985
Bektimirova, M. S., Pille, E. R., Matevosyan, K. SH., Nagieva, F. G.: Acta Virol. 27, 59 (1983)
Bahmanyar, M.: Symp. Series immunobiol. Standard. 21, 231 (1974)
Bahmanyar, M., Fayaz, A., Nour-Salehi, S., Mahammadi, M., Koprowski, H.: J. Amer. Med. Ass. 236, 2571 (1976)
Wiktor, T. J., Plotkin, S. A., Koprowski, H.: Develop. biol. Standard. 40, 3 (1978)
Roumiantzeff, M., Montagnon, B., Vincent-Falquet, J. C., Bussy, L., Charbonnier, C.: Rapport sur l'utilisation du vaccin rabique préparé sur culture de cellules diploides humaines pour l'immunisation avant et après exposition, in: Rabies in the Tropics (Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. eds.) p. 91, Berlin-Heidelberg-New York-Tokyo, Springer-Verlag 1985
Winkler, W. G.: Current status of use of human diploid cell strain rabies vaccine in the U.S., in: Improvements in rabies post-exposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 3, Zagreb Institute of Public Health 1985
Johnson, S. E., Pearson, E. W., Ing, W. K.: Clinical responses in humans to rabies vaccine prepared in MRC-5 diploid cells from Canadian seed virus, in: Rabies in the Tropics (Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. eds.) p. 99, Berlin-Heidelberg-New York-Tokyo, Springer-Verlag 1985
Berlin, B. S., Mitchell, J. R., Burgoyne, G. H., Oleson, D., Brown, W. E., Goswick, C., McCullough, N. B.: J. Amer. Ass. 247, 1776 (1982)
Burgoyne, G. H., Kajiya, K. D., Brown, D. W., Mitchell, J. R.: J. Infect. Dis. 152, 204 (1985)
Montagnon, B. J., Fournier, P., Vincent-Falquet, J. C.: Un nouveau vaccin antirabique à usage humain, in: Rabies in the Topics (Kuwert, E., Merieux, C., Koprowski, H., Bögel, K. eds.) p. 138, Berlin-Heidelberg-New York-Tokyo, Springer-Verlag 1985
Fournier, P., Montagnon, B., Vincent-Falquet, J. C., Ajjan, N., Drucker, J., Roumiantzeff, M.: A new vaccine produced from rabies virus cultivated on Vero cells, in: Improvements in rabies post-exposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 115, Zagreb Institute of Public Health 1985
Svjetlicic, M., Vodopija, I., Smerdel, S., Ljibicic, M., Baklaic, Z., Vincent-Falquet, J. C., Pouradier-Duteil, X., Zayet-Bechelet, M.: Compatibility and immunogenicity of Merieux's purified vero rabies vaccine (PVRV) in healthy subjects, in: Improvements in rabies postexposure treatment (Vodopija, I., Nicholson, K. G., Smerdel, S., Bijok, U. eds.) p. 123, Zagreb Institute of Public Health 1985
Abelseth, M. K.: Symp. Series immunobiol. Standard. 1, 367 (1966)
Abelseth, M. K.: Canad. Vet. J. 8, 221 (1967)
Selimov, M. A.: World Health Organization, V.P.H./RAB.RES./73 I. Add. 1 (1973)
Steck, F., Wandeler, A., Bichsel, P., Capt, S., Haflinger, U., Schneider, L.: Comp. Immun. Microbiol. Infect. Dis. 5, 165 (1982)
Steck, F., Wandeler, A., Bichsel, P., Capt, S., Schneider, L. G.: Zbl. Vet. Med. B 29, 372 (1982)
Wachendorfer, G., Frost, J., Gutman, B., Eskens, U., Schneider, L. G., Dingeldein, W., Hofmann, J.: Rev. Ecol. (Terre et Vie) 40, 257 (1985)
Schneider, L. S., Cox, J. H.: Tierärztl. Umsch. 38, 315 (1983)
Blancou, J.: Rev. sci. tech. Off. int. Epiz. 4, 235 (1985)
Petermann, H. G., Lang, R., Branche, R., Soulebot, J. P., Mackowiak, C.: C. R. Acad. Sci. Paris, 265, 2143 (1967)
Petermann, H. G., Soulebot, J. P., Lang, R., Branche, R.: ibid. 270, 234 (1970) (1970)
Wiktor, T. J., György, E., Schlumberger, H. D., Sokol, F., Koprowski, H.: J. Immunology 110, 269 (1973)
Crick, J., Brown, F.: Nature (London) 222, 92 (1969)
Brown, F., Crick, J.: Symp. Series Immunobiol. Standard 21, 119 (1974)
Cox, J. H., Dietzschold, B., Weiland, F., Schneider, L. G.: Infection and Immunity 30, 572 (1980)
Perrin, P., Thibodeau, L., Dauguet, C., Fritsch, A., Sureau, P.: Ann. Virol. (Inst. Pasteur) 135E, 183 (1984)
Perrin, P., Thibodeau, L., Sureau, P.: Vaccine 3, 325 (1985)
Dietzschold, B., Wiktor, T. J., MacFarlan, R., Varrichio, A.: J. Virology 44, 595 (1982)
MacFarlan, R., Dietzschold, B., Wiktor, T. J., Kiel, M., Houghten, R., Lerner, R. A., Sutclife, J. G., Koprowski, H.: J. of Immunology 133, 2748 (1984)
Reagan, K., Wunner, W. H., Wiktor, T. J., Koprowski, H.: J. of Virology 48, 660 (1983)
Reagan, K. J.: Acta Virologica 29, 15 (1985)
Kieny, M. P., Lathe, R., Drillien, R., Spehnert, S., Skory, S., Schmitt, D., Wiktor, T. J., Koprowski, H., Lecocq, J. P.: Nature 312, 163 (1984)
Lathe, R., Kieny, M. P., Lecocq, J. P., Drillien, R., Wiktor, T. J., Koprowski, H.: Immunization against Rabies Using a Vaccinia-Rabies Recombinant Virus Expressing the Surface Glycoprotein. in Vaccines 85 (Lerner, R. A., Chanock, R. M., Brown, F. eds.) p. 157, Cold Spring Harbor Laboratory 1985
Wiktor, T. J., MacFarlan, R. I., Reagan, K. J., Dietzschold, B., Curtis, P. J., Wunner, W. H., Kieny, M. P., Lathe, R., Lecocq, J. P., Mackett, M., Moss, B., Koprowski, H.: Proc. Natl. Acad. Sci. U.S.A. 81, 7194 (1984)
Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastoret, P. P., Soulebot, J. P., Desmettre, P.: Nature, 322, 373 (1986)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag
About this paper
Cite this paper
Sureau, P. (1987). Rabies vaccine production in animal cell cultures. In: Vertrebrate Cell Culture I. Advances in Biochemical Engineering/Biotechnology, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0000676
Download citation
DOI: https://doi.org/10.1007/BFb0000676
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-17626-8
Online ISBN: 978-3-540-47725-9
eBook Packages: Springer Book Archive